Physician profile
Kalpesh Patel
NPI 1982707212
$381,971.26
in general payments reported to CMS, 2019-2025
39 companies · $79K in 2025
The $79K reported for 2025 was more than what 98% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78K · 2020: $29K · 2021: $31K · 2022: $57K · 2023: $31K · 2024: $79K · 2025: $79K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $125K · Consulting Fee: $40K · Food and Beverage: $12K · Travel and Lodging: $11K · Education: $20.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $125,335.00 |
| Consulting Fee | $40,193.75 |
| Food and Beverage | $11,981.80 |
| Travel and Lodging | $10,687.05 |
| Education | $20.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $168,195.52 | 2019-2025 | General - Therapies, General - Biliary Devices, Axios |
| Abbvie INC. | $107,835.41 | 2019-2025 | |
| Conmed Corporation | $18,948.00 | 2019-2025 | Beamer System, Conmed Biliary, Conmed Generators |
| Olympus Corporation | $18,391.74 | 2023-2025 | Single Use Biliary Balloon Dilator, Evis Exera III Colonovideoscope, Evis Exera III Video System Center |
| Olympus Corporation of The Americas | $16,101.45 | 2019-2025 | Evis Exera III Colonovideoscope, Evis Exera Lll Colonovideoscope, Single Use Aspiration Needle Na-U200h |
| Pentax of America, INC. | $11,976.51 | 2019-2023 | |
| Gi Supply, INC. | $10,715.86 | 2019-2021 | |
| Wilson Cook Medical Incorporated | $7,345.00 | 2025 | Hemospray |
| Ambu INC. | $5,843.73 | 2020-2025 | |
| Lumendi LLC | $5,119.97 | 2019-2021 | |
| Endogastric Solutions, INC | $3,354.30 | 2019-2024 | Esophyx |
| Ambu A/S | $2,700.00 | 2022 | |
| Cook Medical LLC | $960.04 | 2019-2025 | Hemospray, Fusion, Echotip Insight |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $790.36 | 2019-2023 | Xifaxan |
| Medtronic, INC. | $625.44 | 2022-2025 | Endoflip, Gi Genius, Pillcam |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kalpesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.